Literature DB >> 1319065

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

M Gossen1, H Bujard.   

Abstract

Control elements of the tetracycline-resistance operon encoded in Tn10 of Escherichia coli have been utilized to establish a highly efficient regulatory system in mammalian cells. By fusing the tet repressor with the activating domain of virion protein 16 of herpes simplex virus, a tetracycline-controlled transactivator (tTA) was generated that is constitutively expressed in HeLa cells. This transactivator stimulates transcription from a minimal promoter sequence derived from the human cytomegalovirus promoter IE combined with tet operator sequences. Upon integration of a luciferase gene controlled by a tTA-dependent promoter into a tTA-producing HeLa cell line, high levels of luciferase expression were monitored. These activities are sensitive to tetracycline. Depending on the concentration of the antibiotic in the culture medium (0-1 microgram/ml), the luciferase activity can be regulated over up to five orders of magnitude. Thus, the system not only allows differential control of the activity of an individual gene in mammalian cells but also is suitable for creation of "on/off" situations for such genes in a reversible way.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319065      PMCID: PMC49329          DOI: 10.1073/pnas.89.12.5547

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells.

Authors:  M Brown; J Figge; U Hansen; C Wright; K T Jeang; G Khoury; D M Livingston; T M Roberts
Journal:  Cell       Date:  1987-06-05       Impact factor: 41.582

2.  Negative effect of the transcriptional activator GAL4.

Authors:  G Gill; M Ptashne
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

3.  Oestrogen and glucocorticoid responsive elements are closely related but distinct.

Authors:  G Klock; U Strähle; G Schütz
Journal:  Nature       Date:  1987 Oct 22-28       Impact factor: 49.962

4.  Luciferase reporter gene vectors for analysis of promoters and enhancers.

Authors:  S K Nordeen
Journal:  Biotechniques       Date:  1988-05       Impact factor: 1.993

5.  Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids.

Authors:  F Lee; R Mulligan; P Berg; G Ringold
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

6.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

7.  The mouse metallothionein-I gene is transcriptionally regulated by cadmium following transfection into human or mouse cells.

Authors:  K E Mayo; R Warren; R D Palmiter
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

8.  Building a metal-responsive promoter with synthetic regulatory elements.

Authors:  P F Searle; G W Stuart; R D Palmiter
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

9.  Hormone-responsive expression of an endogenous proviral gene of mouse mammary tumor virus after molecular cloning and gene transfer into cultured cells.

Authors:  N E Hynes; N Kennedy; U Rahmsdorf; B Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  A threonine to alanine exchange at position 40 of Tet repressor alters the recognition of the sixth base pair of tet operator from GC to AT.

Authors:  L Altschmied; R Baumeister; K Pfleiderer; W Hillen
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

View more
  1523 in total

1.  Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta.

Authors:  A Rodriguez; M Armstrong; D Dwyer; E Flemington
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Identification and classification of p53-regulated genes.

Authors:  J Yu; L Zhang; P M Hwang; C Rago; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

3.  Cytokine receptor common beta chain as a potential activator of cytokine withdrawal-induced apoptosis.

Authors:  S F Lee; H M Huang; J R Chao; S Lin; H F Yang-Yen; J J Yen
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

4.  A general strategy to enhance the potency of chimeric transcriptional activators.

Authors:  S Natesan; E Molinari; V M Rivera; R J Rickles; M Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 5.  Overview of vector design for mammalian gene expression.

Authors:  R J Kaufman
Journal:  Mol Biotechnol       Date:  2000-10       Impact factor: 2.695

6.  Decoding apparatus for eukaryotic selenocysteine insertion.

Authors:  R M Tujebajeva; P R Copeland; X M Xu; B A Carlson; J W Harney; D M Driscoll; D L Hatfield; M J Berry
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

Review 7.  Advanced transgenic and gene-targeting approaches.

Authors:  X Gao; A Kemper; B Popko
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

8.  Rapid characterization of green fluorescent protein fusion proteins on the molecular and cellular level by fluorescence correlation microscopy.

Authors:  R Brock; G Vàmosi; G Vereb; T M Jovin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

9.  Identification of the histamine H1 receptor gene as a differentially repressed target of the human TR2 orphan receptor.

Authors:  H J Lee; Y F Lee; C Chang
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

10.  Inhibition of luciferase expression by synthetic hammerhead ribozymes and their cellular uptake.

Authors:  B Bramlage; S Alefelder; P Marschall; F Eckstein
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.